Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce-Reference-Cited by-同舟云学术

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce

Published:2017-02 Issue:2 Volume:25 Page:512-522
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Herzog Roland W.,Nichols Timothy C.,Su Jin,Zhang Bei,Sherman Alexandra,Merricks Elizabeth P.,Raymer Robin,Perrin George Q.,Häger Mattias,Wiinberg Bo,Daniell Henry

Funder

NIH

Novo Nordisk

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference42 articles.

1. Targeted approaches to induce immune tolerance for Pompe disease therapy;Doerfler;Mol. Ther. Methods Clin. Dev.,2016

2. Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice;Su;Plant Biotechnol. J.,2015

3. Immune tolerance in haemophilia: the long journey to the fork in the road;DiMichele;Br. J. Haematol.,2012

4. Advances in the clinical management of inhibitors in hemophilia A and B;Leissinger;Semin. Hematol.,2016

5. Mechanism of oral tolerance induction to therapeutic proteins;Wang;Adv. Drug Deliv. Rev.,2013

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment;Expert Opinion on Investigational Drugs;2024-08-11

2. The use of Bacillus subtilis as a cost-effective expression system for production of Cholera Toxin B fused factor VIII epitope regions applicable for inducing oral immune tolerance;Folia Microbiologica;2024-04-29

3. Factor IX administration in the skin primes inhibitor formation and sensitizes hemophilia B mice to systemic factor IX administration;Research and Practice in Thrombosis and Haemostasis;2023-11

4. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?;Journal of Thrombosis and Haemostasis;2023-11

5. Delivery of biologics: Topical administration;Biomaterials;2023-11